Altered levels of circulating miRNAs are associated Schistosoma japonicum infection in mice

Parasites and Vectors

Volumn 8, Issue 1, 2015, Pages

  Zhu, Lihui ^a   Dao, Jinwei ^a   Du, Xiaoli ^a   Li, Hao ^a   Lu, Ke ^a   Liu, Jinming ^a   Cheng, Guofeng ^a  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

Host parasite interaction; MicroRNAs; Pathogenesis; Schistosome; Schistosomiasis

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 1; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BIOLOGICAL FUNCTIONS; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HOST PARASITE INTERACTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS; SCHISTOSOMIASIS JAPONICA; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGY; BLOOD; DISEASE MODEL; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

MUS; PLATYHELMINTHES; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

ANIMALS; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; MICE; MICROARRAY ANALYSIS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS JAPONICA;

EID: 84927135502     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-015-0806-5     Document Type: Article

References (48)

1. Gryseels B. Schistosomiasis. Infec Dis Clin North Am. 2012;26:383-97.
2. Colley DG, Bustinduy AL, Secor E, King CH. Human schistosomiasis. Lancet. 2014;383:2253-64.
3. Zhang ZJ, Zhu R, Ward MP, Xu WH, Zhang LJ, Guo JG, et al. Long-term impact of the world bank loan project for schistosomiasis control: A comparison of the spatial distribution of schistosomiasis risk in China. Plos Neglect Trop D. 2012;6:e1620.
4. S-h X, Catto BA, Webster LT. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J Infect Dis. 1985;151:1130-7.
5. Bergquist R, Utzinger J, McManus DP. Trick or treat: the role of vaccines in integrated schistosomiasis control. Plos Neglect Trop D. 2008;2:e244.
6. Wang W, Wang L, Liang YS. Susceptibility or resistance of praziquantel in human schistosomiasis: A review. Parasitol Res. 2012;111:1871-7.
7. Bushati N, Cohen SM. MicroRNA functions. Annu Rev Cell Dev Bi. 2007;23:175-205.
8. Cheng GF, Jin YX. MicroRNAs: Potentially important regulators for schistosome development and therapeutic targets against schistosomiasis. Parasitology. 2012;139:669-79.
9. Devaney E, Winter AD, Britton C. MicroRNAs: A role in drug resistance in parasitic nematodes? Trends Parasitol. 2010;26:428-33.
10. Liu QA, Tuo WB, Gao HW, Zhu XQ. MicroRNAs of parasites: current status and future perspectives. Parasitol Res. 2010;107:501-7.
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513-8.
12. Huang XY, Liang MH, Dittmar R, Wang L. Extracellular microRNAs in urologic malignancies: chances and challenges. Int J Mol Sci. 2013;14:14785-99.
13. Hull ML, Nisenblat V. Tissue and circulating microRNA influence reproductive function in endometrial disease. Reprod Biomed Online. 2013;27:515-29.
14. Liu JB, Zhou CC, Ma QH, Jin QY, Yang ZB. miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma. Tumor Biol. 2015;36:219-25.
15. Cheng GF, Luo R, Hu C, Cao J, Jin YX. Deep sequencing-based identification of pathogen-specific microRNAs in the plasma of rabbits infected with Schistosoma japonicum. Parasitology. 2013;140:1751-61.
16. Hoy AM, Lundie RJ, Ivens A, Quintana JF, Nausch N, Forster T, et al. Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection. Plos Neglect Trop D. 2014;8:e2701.
17. He X, Sai X, Chen C, Zhang YB, Xu XD, Zhang DM, et al. Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy. Parasite Vector. 2013;6:272.
18. Zhu L, Liu J, Cheng G. Role of microRNAs in schistosomes and schistosomiasis. Front Cell Infect Microbiol. 2014;4:165.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods. 2001;25:402-8.
20. Lian H, Liu WS, Liu QA, Jin HT, Sun YC, Li JP, et al. A laboratory-attenuated vesicular stomatitis virus induces apoptosis and alters the cellular microRNA expression profile in BHK cells. Arch Virol. 2010;155:1643-53.
21. Zhao YN, Li WF, Li F, Zhang Z, Dai YD, Xu AL, et al. Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway. Biochem Bioph Res Co. 2013;435:597-602.
22. Wang F, Xiong L, Huang X, Zhao T, Wu LY, Liu ZH, et al. miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells. Stem Cell Res. 2013;11:657-67.
23. Peti W, Page R. Molecular basis of MAP kinase regulation. Protein Sci. 2013;22:1698-710.
24. Koul HK, Pal M, Koul S. Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer. 2013;4:342-59.
25. Cervenka I, Wolf J, Masek J, Krejci P, Wilcox WR, Kozubik A, et al. Mitogen-activated protein kinases promote WNT/beta-catenin signaling via phosphorylation of LRP6. Mol Cell Biol. 2011;31:179-89.
26. Sato M. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm-Venereol. 2006;86:300-7.
27. Zeller E, Mock K, Horn M, Colnot S, Schwarz M, Braeuning A. Dual-specificity phosphatases are targets of the Wnt/beta-catenin pathway and candidate mediators of beta-catenin/Ras signaling interactions. Biol Chem. 2012;393:1183-91.
28. Han H, Peng J, Hong Y, Zhang M, Han Y, Liu D, et al. MicroRNA expression profile in different tissues of BALB/c mice in the early phase of Schistosoma japonicum infection. Mol Biochem Parasitol. 2013;188:1-9.
29. Peng J, Gobert GN, Hong Y, Jiang W, Han H, McManus DP, et al. Apoptosis governs the elimination of Schistosoma japonicum from the non-permissive host Microtus fortis. Plos One. 2011;6:e21109.
30. Correa-Oliveira R, Malaquias LCC, Falcao PL, Viana IRC, Bahia-Oliveira LMG, Silveira AMS, et al. Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection. Braz J Med Biol Res. 1998;31:171-7.
31. Carneiro-Santos P, Alves-Oliveira LF, Correa-Oliveira R, Hagan P. P38 mitogen-activated protein kinase influence on the production of IL-10 in human Schistosomiasis mansoni. Parasite Immunol. 2002;24:493-7.
32. Wang YQ, Huang YM, Guan F, Xiao Y, Deng J, Chen HY, et al. Hypoxia-inducible factor-1alpha and MAPK co-regulate activation of hepatic stellate cells upon hypoxia stimulation. Plos One. 2013;8:e74051.
33. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6:99-104.
34. Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149:515-24.
35. Oneyama C, Morii E, Okuzaki D, Takahashi Y, Ikeda J, Wakabayashi N, et al. MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression. Oncogene. 2012;31:1623-35.
36. Yoon S, Choi YC, Lee S, Jeong Y, Yoon J, Baek K. Induction of growth arrest by miR-542-3p that targets survivin. FEBS Lett. 2010;584:4048-52.
37. He T, Qi FF, Jia L, Wang S, Song N, Guo LF, et al. MicroRNA-542-3p inhibits tumour angiogenesis by targeting Angiopoietin-2. J Pathol. 2014;232:499-508.
38. Hong L, Han Y, Zhang HW, Zhao QC, Qiao Y. miR-210: A therapeutic target in cancer. Expert Opin Ther Tar. 2013;17:21-8.
39. Wulczyn FG, Smirnova L, Rybak A, Brandt C, Kwidzinski E, Ninnemann O, et al. Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB J. 2007;21:415-26.
40. Zhao C, Sun G, Li S, Lang MF, Yang S, Li W, et al. MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling. Proc Natl Acad Sci U S A. 2010;107:1876-81.
41. Rinaldi A, Vincenti S, De Vito F, Bozzoni I, Oliverio A, Presutti C, et al. Stress induces region specific alterations in microRNAs expression in mice. Behav Brain Res. 2010;208:265-9.
42. Zha RP, Guo WJ, Zhang ZF, Qiu ZP, Wang QF, Ding J, et al. Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin beta 1 in hepatocellular carcinoma. Plos One. 2014;9:e87665.
43. Zhou T, Zhang GJ, Liu ZL, Xia SS, Tian HP. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int J Colorectal Dis. 2013;28:19-24.
44. Li ML, Guan XF, Sun YQ, Mi J, Shu XH, Liu F, et al. miR-92a family and their target genes in tumorigenesis and metastasis. Exp Cell Res. 2014;323:1-6.
45. Wang J, Huang SK, Zhao M, Yang M, Zhong JL, Gu YY, et al. Identification of a circulating microRNA signature for colorectal cancer detection. Plos One. 2014;9:e87451.
46. Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Brit J Cancer. 2014;110:2291-9.
47. He F, Lv P, Zhao X, Wang X, Ma X, Meng W, et al. Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction. Mol Cell Biochem. 2014;394:137-44.
48. Sheinerman KS, Tsivinsky VG, Abdullah L, Crawford F, Umansky SR. Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. Aging-Us. 2013;5:925-38.